---
title: "Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis"
collection: publications
permalink: /publication/2024 Feb-van_Ouwerkerk_L_Semin Arthritis Rheum_2024
excerpt: "To evaluate if initially starting glucocorticoid (GC) bridging leads to a higher probability of long-term GC and biological (b)DMARD use in rheumatoid arthritis (RA)-patients."
date: 2024 Feb
venue: "Semin Arthritis Rheum"
paperurl: "https://doi.org/10.1016/j.semarthrit.2023.152305"
citation: "van Ouwerkerk L, Bergstra SA, Maarseveen TD, Huizinga TWJ, Knevel R, Allaart CF. (2024) &quot;Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis&quot; <i>Semin Arthritis Rheum. 2024 Feb;64:152305. doi: 10.1016/j.semarthrit.2023.152305. Epub 2023 Nov 10.</i>"
---

<a href='https://doi.org/10.1016/j.semarthrit.2023.152305'>Download paper here</a>

To evaluate if initially starting glucocorticoid (GC) bridging leads to a higher probability of long-term GC and biological (b)DMARD use in rheumatoid arthritis (RA)-patients.

Recommended citation: van Ouwerkerk L, Bergstra SA, Maarseveen TD, Huizinga TWJ, Knevel R, Allaart CF. (2024) &quot;Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis&quot; <i>Semin Arthritis Rheum. 2024 Feb;64:152305. doi: 10.1016/j.semarthrit.2023.152305. Epub 2023 Nov 10.</i>